RUNX1 and mixed phenotype acute leukemia: In one of the largest series of MPAL cases to date, we corroborate previous findings with an enriched detection of RUNX1 mutations, along with the discovery of unreported mutations (MAP3K) that may be amenable to therapeutic manipulation.